References
- 1. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: 1–266.
- 2. Chadban SJ, Briganti EM, Kerr PG et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol 2003; 14: 131–138.10.1097/01.ASN.0000070152.11927.4A
- 3. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038–2047.10.1001/jama.298.17.2038
- 4. Hallan SI, Coresh J, Astor BC et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol 2006; 17: 2275–2284.1679051110.1681/ASN.2005121273
- 5. Wen CP, Cheng TY, Tsai MK et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008; 371: 2173–2182.10.1016/S0140-6736(08)60952-6
- 6. Levey AS, de Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011; 80: 17–28.10.1038/ki.2010.483
- 7. Lysaght MJ. Maintenance dialysis population dynamics: current trends and long-term implications. J Am Soc Nephrol 2002; 13: 37–40.10.1681/ASN.V13suppl_1s37
- 8. Collins AJ, Foley RN, Herzog C et al. United States Renal Data System, USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and EndStage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda, MD, 2011.
- 9. Iversen, P. and Brun, C. Aspiration biopsy of the kidney. Am J Med. 1951; 11: 324–3301487783710.1016/0002-9343(51)90169-6
- 10. Madaio MP.Renal biopsy. Kidney Int 1990; 38:529-543.223249610.1038/ki.1990.2362232496
- 11. Gerth, J., Busch, M., Illner, N. et al. Are tissue samples from two different anatomical areas of the kidney necessary for adequate diagnosis?. Clin Nephrol. 2010; 74: 258–265.10.5414/CNP74258
- 12. Whittier, W.L. Complications of the percutaneous kidney biopsy. Adv Chronic Kidney Dis. 2012; 19: 179–187.10.1053/j.ackd.2012.04.00322578678
- 13. Roth, R., Parikh, S., Makey, D. et al. When size matters: diagnostic value of kidney biopsy according to the gauge of the biopsy needle. Am J Nephrol. 2013; 37: 249–25410.1159/000347219
- 14. Eiro, M., Katoh, T., and Watanabe, T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol. 2005; 9: 40–4510.1007/s10157-004-0326-7
- 15. Manno, C., Strippoli, G.F., Arnesano, L. et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 2004; 66: 1570–157710.1111/j.1523-1755.2004.00922.x
- 16. Manno, C., Strippoli, G.F., Arnesano, L. et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 2004; 66: 1570–157710.1111/j.1523-1755.2004.00922.x
- 17. Stratta P, Canavese C, Marengo M, Mesiano P, Besso L, Quaglia M, Bergamo D, Monga G, Mazzucco G, Ciccone G. Risk management of renal biopsy: 1387 cases over 30 years in a single centre. Eur J Clin Invest. 2007;37:954–963.10.1111/j.1365-2362.2007.01885.x
- 18. Hergesell O, Felten H, Andrassy K, Kühn K, Ritz E. Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant. 1998;13:975–977.10.1093/ndt/13.4.975
- 19. Manno C, Strippoli GF, Arnesano L, Bonifati C, Campobasso N, Gesualdo L, Schena FP. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int. 2004;66:1570–1577.10.1111/j.1523-1755.2004.00922.x
- 20. Mendelssohn DC, Cole EH. Outcomes of percutaneous kidney biopsy, including those of solitary native kidneys. Am J Kidney Dis. 1995;26:580–585.10.1016/0272-6386(95)90592-8
- 21. Burstein DM, Schwartz MM, Korbet SM. Percutaneous renal biopsy with the use of real-time ultrasound. Am J Nephrol. 1991;11:195–200.10.1159/0001683031962666
- 22. Ginsburg JC, Fransman SL, Singer MA, Cohanim M, Morrin PA. Use of computerized tomography to evaluate bleeding after renal biopsy. Nephron. 1980;26:240–243.10.1159/0001819927422051
- 23. Ralls PW, Barakos JA, Kaptein EM, Friedman PE, Fouladian G, Boswell WD, Halls J, Massry SG. Renal biopsy-related hemorrhage: frequency and comparison of CT and sonography. J Comput Assist Tomogr. 1987;11:1031–1034.10.1097/00004728-198711000-00021
- 24. Tøndel C, Vikse BE, Bostad L, Svarstad E. Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010. Clin J Am Soc Nephrol. 2012;7:1591–1597.10.2215/CJN.02150212
- 25. Eiro M, Katoh T, Watanabe T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol. 2005;9:40–45.10.1007/s10157-004-0326-7
- 26. Hedges SJ, Dehoney SB, Hooper JS, Amanzadeh J, Busti AJ. Evidence-based treatment recommendations for uremic bleeding. Nat Clin Pract Nephrol. 2007;3:138–153.10.1038/ncpneph0421
- 27. Corapi KM, Chen JL, Balk EM, Gordon CE. Bleeding complications of native kidney biopsy: a systematic review and meta-analysis. Am J Kidney Dis. 2012;60:62–73.10.1053/j.ajkd.2012.02.330
- 28. Korbet SM, Volpini KC, Whittier WL. Percutaneous renal biopsy of native kidneys: a single-center experience of 1,055 biopsies. Am J Nephrol. 2014;39:153–162.10.1159/000358334
- 29. Gupta RK, Balogun RA. Native renal biopsies: complications and glomerular yield between radiologists and nephrologists. J Nephrol. 2005; 18:553–558.
- 30. Nass K, O’Neill WC. Bedside renal biopsy: ultrasound guidance by the nephrologist. Am J Kidney Dis. 1999;34:955–959.10.1016/S0272-6386(99)70058-2
- 31. Bollée G, Martinez F, Moulin B, Meulders Q, Rougier JP, Baumelou A, Glotz D, Subra JF, Ulinski T, Vrigneaud L, et al. Renal biopsy practice in France: results of a nationwide study. Nephrol Dial Transplant. 2010;25:3579–3585.10.1093/ndt/gfq25420466684
- 32. Cluzel P, Martinez F, Bellin MF, Michalik Y, Beaufils H, Jouanneau C, Lucidarme O, Deray G, Grenier PA. Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: comparison of sampling effectiveness and complications. Radiology. 2000;215:689–693.10.1148/radiology.215.3.r00ma0768910831685
- 33. Fine DM, Arepally A, Hofmann LV, Mankowitz SG, Atta MG. Diagnostic utility and safety of transjugular kidney biopsy in the obese patient. Nephrol Dial Transplant. 2004;19:1798–1802.1512888110.1093/ndt/gfh24615128881
- 34. Cluzel P, Martinez F, Bellin MF, Michalik Y, Beaufils H, Jouanneau C, Lucidarme O, Deray G, Grenier PA. Transjugular versus percutaneous renal biopsy for the diagnosis of parenchymal disease: comparison of sampling effectiveness and complications. Radiology. 2000; 215:689–693.10.1148/radiology.215.3.r00ma0768910831685
- 35. Misra S, Gyamlani G, Swaminathan S, Buehrig CK, Bjarnason H, McKusick MA, Andrews JC, Johnson CM, Fervenza FC, Leung N. Safety and diagnostic yield of transjugular renal biopsy. J Vasc Interv Radiol. 2008; 19:546–551.1837529910.1016/j.jvir.2007.12.44718375299
- 36. Madairo MP.Renal biopsy.Kidney Int 1990; 38;529-543.10.1038/ki.1990.2362232496
- 37. Danovitch GM, Nissenson AR. The role of renal biopsy in determining therapy and prognosis in renal diasease. Am. J Nephrology 1982; 2:179-184.10.1159/000166641
- 38. Pirani CL.Evaluation of kidney biopsy specimens:In : Tisher CC, Brenner BM,eds.Renal Pathology with Clinical and Functional Correlations.Lippincott, Philadelphia,1994;85-115.
- 39. Ponticelli C, Mihatsch MJ.Renal biopsy: performance and interpretation.In: Cameron JS, Davison AM, Ritz E, eds.Oxford Texbook of Clinical Nephrology.Oxford Medical Publications, Oxfort.1992;141-155
- 40. Appel GB, Kunis CL.Acute tubulointerstitial nephritis. In Cottran R, ed. Contemporary Issue in Nephrology, Vol.10, Tubular Interstitial Nephropaties,Churchill, Livingstone, New York, 1983;151-185.
- 41. Hooke DH, Gee DC,Atkins RC.Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 1987;32:964-972.349568910.1038/ki.1987.933495689